Notice to providers: Avian flu 2025 (bird flu)
The following guidance to health care providers has been issued by Norton Healthcare’s infection prevention and employee health department. Current situation in Kentucky On Jan. 16, 2025, the Centers for Disease Control and Prevention (CDC) […]
View more
Measles guidance for providers
The following measles guidance for providers has been issued by Norton Healthcare’s department of infection prevention and employee health. When should children receive MMR (measles-mumps-rubella) vaccine? Do we need to vaccinate children early because of […]
View more
Antimicrobial stewardship
The Norton Healthcare Antimicrobial Stewardship Program was recognized this year as the first and only antimicrobial stewardship center of excellence in the United States by the British Society of Antimicrobial Chemotherapy. The international collaboration is […]
View more
Study looks at how to detect RSV in adults
Norton Infectious Diseases Institute has been selected by Pfizer as the only site in United States to study how to effectively detect respiratory syncytial virus (RSV) in adults. “For the most part, RSV attention has [...]
View more
HPV and your lesbian patients
Lesbians may be at higher risk for HPV because of historical health care barriers that may have caused reluctance to get preventive screenings. Making matters worse, much of the discussion around sexually transmitted infections (STIs) […]
View more
CDC guidelines for sexually transmitted infection (STI) screening
The following guide for sexually transmitted infection (STI)/sexually transmitted disease (STD) screening is adapted from the Centers for Disease Control and Prevention (CDC). Chlamydia Assigned female at birth Sexually active under 25 years of age […]
View more
Norton Healthcare providing Bamlanivimab for COVID-19 patients at risk of hospitalization
Norton Healthcare is making monoclonal antibody treatment Bamlanivimab available under the Food and Drug Administration’s emergency use authorization for certain patients at high risk for requiring hospitalization for COVID-19. We are fortunate to have extensive […]
View more
All Norton Healthcare providers now can order convalescent plasma for severe or critical COVID-19 patients
Under an emergency use authorization by the Food and Drug Administration (FDA), all Norton Healthcare providers can order convalescent plasma therapy for confirmed COVID-19 hospitalized patients with severe or critical symptoms. Norton Healthcare hospitals have […]
View more
Norton Healthcare to offer COVID-19 Long-term Care Clinic for patients with lasting side effects
Norton Healthcare will launch a COVID-19 Long-term Care Clinic for adult patients who continue to experience side effects after having battled the coronavirus. “Norton Healthcare has been a regional leader in caring for patients with […]
View more
Critically ill COVID-19 patients who received convalescent plasma leaving hospital
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been able to go home. Norton […]
View more
New algorithm available for C. difficile testing
Effective Monday, Sept. 9, Norton Healthcare replaced the algorithm for C. difficile testing with a new approach designed to provide clinicians greater clarity regarding the significance of a positive result. The new algorithm will begin […]
View more
Sepsis information for providers
Define sepsis Systemic inflammatory response syndrome (SIRS) criteria Temperature > 38.3 C (> 100.9 F) Temperature < 36.0 C (< 96.8 F) Heart rate > 90 Respiratory rate > 20 White blood cell >12,000 or […]
View more